Trial Profile
A Randomized, Multi-center, Parallel Group, Double Blind, Study to Assess the Safety of QMF Twisthaler (500/400 microg) and Mometasone Furoate Twisthaler (400 microg) in Adolescent and Adult Patients With Persistent Asthma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2017
Price :
$35
*
At a glance
- Drugs Indacaterol/mometasone (Primary) ; Mometasone
- Indications Asthma
- Focus Pharmacogenomic; Therapeutic Use
- 05 Sep 2012 Efficacy results presented at the 22nd Annual Congress of the European Respiratory Society.
- 05 Sep 2012 Efficacy and tolerability results presented at the 22nd Annual Congress of the European Respiratory Society.
- 04 Jun 2012 Actual patient number changed from 1500 to 2283 as reported by ClinicalTrials.gov.